Health
BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy – Clinical OMICs News
Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However,…
Results from an analysis of COVID-19 vaccination data from Israel, where most of the population have now been vaccinated, confirm earlier Phase III data and show over 90% protection from asymptomatic and symptomatic disease with the BioNTech/Pfizer vaccine.
Notably, this efficacy held true despite several variants of concern circulating in Israel at the time of vaccination, with the UK B.1.1.7 variant being the most common. While efficacy was good, there was a decrease in efficacy in much older…
-
Noosa News23 hours agoFatal Traffic Crash, South Bingera
-
Noosa News15 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News20 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
General21 hours agoVacherot becomes lowest-ranked ATP Masters winner after defeating his cousin Rinderknech in Shanghai